Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
OTAMIXABAN
Not marketed
Acute Coronary Syndrome
EFC6204TAONCT01076764Publication's reference
OTAMIXABAN
Not marketed
Hepatic Impairment
POP6207NANCT01126086
OTAMIXABAN
Not marketed
Renal Impairment
POP6537NANCT01120314Summary
OXALIPLATIN
Eloxatin
Cancer, Pediatric Malignancies
ARD5531 (L795)NASummary
OXALIPLATIN
Eloxatin
Biliary Tract Neoplasms
C_8552EXIBITNCT00174564Summary
OXALIPLATIN
Eloxatin
Colorectal Neoplasms
C_8601CORENCT00174616Summary
OXALIPLATIN
Eloxatin
Esophageal Neoplasms
EFC_7127NANCT00259402Summary
OXALIPLATIN
Eloxatin
Cancer, Germ Cell
EFC_7154NASummary
OXALIPLATIN
Eloxatin
Head and Neck neoplasms
EFC_7276FOL FOX 4NCT00611754Summary
OXALIPLATIN
Eloxatin
Neoplasms
EFC_7407NANCT00611962Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted